DUBLIN – (BUSINESS WIRE) – The “Blood Screening Market by Product (Reagents and Kits, Instruments, Software), Technology (NAAT [Real-time PCR], ELISA [CLIA, FIA, CI], Rapid tests, western blotting, NGS) and end users (blood banks, hospitals, laboratories) – “Global forecast to 2027” report has been added ResearchAndMarkets.com to offer.

The blood testing market is expected to grow from 2020 to 2027 at a CAGR of 6.9% to $ 3.56 billion by 2027.

Driving factors are above all increasing blood donations and transfusion-related screenings, the increasing prevalence of infectious diseases, the growing geriatric population and the increasing awareness of transfusion-related diseases.

In addition, factors such as emerging markets in developing and underdeveloped countries as well as the development and introduction of advanced technologies are expected to create high growth opportunities for market participants during the forecast period.

However, it is expected that factors such as the lack of laws, regulations, and guidelines regarding blood collection and the development of alternative technologies to replace blood screening will to some extent hamper the growth of this market.

In terms of product, the Reagents & Kits segment had the largest market share worldwide in 2020 due to the wide range of diagnostic applications of various NAT and ELISA kits, the recurring costs of reagents and the increasing prevalence of infectious diseases.

In terms of technology, the nucleic acid amplification segment had the largest share of this market in 2020. The large share of this segment is mainly attributed to the superiority of this technology in the early detection of diseases due to its high sensitivity and specificity.

In terms of end consumers, the blood banks segment had the largest share of this market in 2020. The large portion of this segment is due to factors such as increasing blood donations, increased awareness of transfusion-related diseases and the growing prevalence of infectious diseases.

The major players in the Blood Screening Market are

  • Abbott Laboratories (USA)

  • OriGene Technologies Inc. (USA)

  • BioAim Scientific Inc. (Canada)

  • bioMerieux Inc. (France)

  • Bio-Rad Laboratories Inc. (LAUS)

  • Grifols SA (Spain)

  • Immuno-Biological Laboratories Co. Ltd. (Japan)

  • Biovision Inc. (USA)

  • Becton Dickinson and Company (USA)

  • Booster Biological Technology (USA)

  • Cusabio Technology LLC (USA)

  • Danaher Corporation (USA)

  • Demeditec Diagnostics GmbH (Germany)

  • F. Hoffmann-La Roche AG (Switzerland)

Key topics covered:

1 Introduction

2. Research methodology

3. Summary

4. Market insights

4.1. introduction

4.2. driver

4.2.1. Increasing number of blood donations and transfusion-related screenings

4.2.2. Growing prevalence of infectious diseases

4.2.3. Increasing government initiatives

4.3. Restrictions

4.3.1. Lack of laws, regulations and guidelines

4.3.2. Development of alternative technologies

4.4. opportunities

4.4.1. Developing countries

4.4.2. Technological advances

4.5. Challenges

4.5.1. High cost of NAT testing in developing countries

4.6. Covid-19 impact assessment

5. Global Blood Testing Market By Product

5.1. introduction

5.2. Reagents & Kits

5.2.1. Nucleic Acid Amplification Test (NAAT)

5.2.2. ELISA

5.2.3. Other reagents & kits

5.3. Instruments

5.4. Software and services

6. Global Blood Testing Market By Technology

6.1. introduction

6.2. Nucleic acid amplification (NAAT)

6.2.1. Transcription Mediated Amplification (TMA)

6.2.2. Real-time polymerase chain reaction (RT-PCR)

6.3. Enzyme Linked Immunosorbent Assay (ELISA)

6.3.1. Chemiluminescent Immunoassay (CLIA)

6.3.2. Fluorescent Immunoassays (FIA)

6.3.3. Colorimetric Immunoassays (CI)

6.4. Rapid tests

6.5. Western blotting

6.6. Next Generation Sequencing (NGS)

7. Global Blood Tests Market By End User

7.1. introduction

7.2. Blood banks

7.3. Hospitals

7.4. Clinical laboratories

8. Global Blood Testing Market By Geography

9. Competitive landscape

9.1. introduction

9.2. Important growth strategies

9.3. Competitive comparison

9.4. Market share analysis by major players (2019)

9.4.1. Abbott Laboratories

9.4.2. Becton, Dickinson and Company

9.4.3. F. Hoffmann-La Roche Ltd

10. Company profiles (business overview, financial overview, product portfolio and strategic development)

Please visit https://www.researchandmarkets.com/r/8x45e4 for more information on this report


Please enter your comment!
Please enter your name here